EDEN PRAIRIE, Minn., Jan 27, 2005 (BUSINESS WIRE) -- SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery technologies to the medical device industry, today announced that it will host a live Webcast of its annual meeting on Monday, January 31, at 4 p.m. CT.
Dale Olseth, SurModics' chairman and chief executive officer, Bruce Barclay, president and chief operating officer, and Phil Ankeny, chief financial officer and vice president of business development, will discuss achievements and financial results for the fiscal year ended September 30, 2004, and the first quarter of fiscal 2005, as well as the company's strategic plan for future growth. In addition, Eugene de Juan, Jr., M.D., Founder and former Chairman of InnoRx will discuss the market opportunity in ophthalmology and the platform technology which is being developed by SurModics following its recent acquisition of InnoRx.
To access the Webcast, go to the investor relations portion of the Company's Web site, www.surmodics.com, on the day of the annual meeting and click on the Webcast icon. In addition, the annual meeting audio and slide presentation will be archived on the Company's Web site following the meeting.
About SurModics, Inc.
SurModics, Inc., a leading provider of surface modification technology, licenses its patented coating processes to medical device manufacturers around the world. A significant portion of SurModics' revenue is generated through royalties on the sale of coated products. SurModics' Internet address is www.surmodics.com.
SOURCE: SurModics, Inc.
Phil Ankeny, 952-829-2700